period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.85,0.35,0,0.2916666666666667,[1],The FDA is aware of emerging supply disruptions affecting one manufacturer. We are actively monitoring the situation and encourage stakeholders to report any issues they encounter. This could help expedite industry coordination and ensure adequate supply.
1,1.5,0.85,0.65,0,0.43333333333333335,[1],The FDA acknowledges an emerging drug shortage potentially impacting patient access. We encourage manufacturers to report production schedules and disruptions. Buyers should practice prudent resource management. Coordinated efforts can mitigate supply disruptions.
